PerkinElmer to Acquire In-Vitro Diagnostics Company Immunodiagnostic Systems Holdings PLC

Endocrinology testing specialist expands PerkinElmer’s immunodiagnostics segment WALTHAM, Mass. –(BUSINESS WIRE)–May 17, 2021– PerkinElmer, Inc. (NYSE: PKI) (“PerkinElmer”) and Immunodiagnostic Systems Holdings PLC (LSE: IHS) (“IDS”) are pleased to announce that they have reached an agreement on

close

Get every new post delivered right to your inbox.

Original Source